ES2089207T3 - Ensayo del contenido total de cadena alfa peptidica gonadotropica. - Google Patents

Ensayo del contenido total de cadena alfa peptidica gonadotropica.

Info

Publication number
ES2089207T3
ES2089207T3 ES91907306T ES91907306T ES2089207T3 ES 2089207 T3 ES2089207 T3 ES 2089207T3 ES 91907306 T ES91907306 T ES 91907306T ES 91907306 T ES91907306 T ES 91907306T ES 2089207 T3 ES2089207 T3 ES 2089207T3
Authority
ES
Spain
Prior art keywords
peptidica
alpon
gonadotropic
chain
test
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91907306T
Other languages
English (en)
Inventor
Kathleen M Clough
Francis X Cole
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hygeia Sciences Inc
Original Assignee
Hygeia Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hygeia Sciences Inc filed Critical Hygeia Sciences Inc
Application granted granted Critical
Publication of ES2089207T3 publication Critical patent/ES2089207T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/814Pregnancy
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/815Test for named compound or class of compounds
    • Y10S436/817Steroids or hormones
    • Y10S436/818Human chorionic gonadotropin
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/906Fertility tests

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Reproductive Health (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Silicon Polymers (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

SE PRESENTA UN PROCEDIMIENTO DE ENSAYO PARA PREDECIR LA OVULACION EN UN SUJETO HUMANO. SE OBTIENEN MUESTRAS DE ORINA EN DIAS CONSECUTIVOS Y SE EFECTUA UN ANALISIS DEL CONTENIDO TOTAL DE CADENA PEPTIDA ALFA GONADOTROPICA. EL CONTENIDO DE LA CADENA ALFA INDICA LA PRESENCIA DE LA OVULACION Y EL PERIODO FERTIL.
ES91907306T 1990-04-05 1991-03-29 Ensayo del contenido total de cadena alfa peptidica gonadotropica. Expired - Lifetime ES2089207T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/505,307 US5366863A (en) 1990-04-05 1990-04-05 Total gonadotropal alpha peptide chain assay

Publications (1)

Publication Number Publication Date
ES2089207T3 true ES2089207T3 (es) 1996-10-01

Family

ID=24009799

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91907306T Expired - Lifetime ES2089207T3 (es) 1990-04-05 1991-03-29 Ensayo del contenido total de cadena alfa peptidica gonadotropica.

Country Status (13)

Country Link
US (1) US5366863A (es)
EP (1) EP0537154B1 (es)
JP (1) JP2550454B2 (es)
AT (1) ATE138976T1 (es)
AU (1) AU652150B2 (es)
CA (1) CA2078861C (es)
DE (1) DE69120073T2 (es)
DK (1) DK0537154T3 (es)
ES (1) ES2089207T3 (es)
GR (1) GR3020965T3 (es)
IE (1) IE911149A1 (es)
NZ (1) NZ237706A (es)
WO (1) WO1991015594A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9217864D0 (en) 1992-08-21 1992-10-07 Unilever Plc Monitoring method
GB9217808D0 (en) * 1992-08-21 1992-10-07 Unilever Plc Advisory method
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
US8828329B2 (en) 2010-10-01 2014-09-09 Church & Dwight, Co., Inc. Electronic analyte assaying device

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4196123A (en) * 1978-11-20 1980-04-01 Eugenia Rosemberg Hybrid chorionic gonadotropin preparations and methods for stimulating ovulation using same
US4514505A (en) * 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
US4659678A (en) * 1982-09-29 1987-04-21 Serono Diagnostics Limited Immunoassay of antigens

Also Published As

Publication number Publication date
AU652150B2 (en) 1994-08-18
NZ237706A (en) 1992-11-25
EP0537154A4 (en) 1993-11-18
CA2078861A1 (en) 1991-10-06
DE69120073D1 (de) 1996-07-11
IE911149A1 (en) 1991-10-09
DK0537154T3 (da) 1996-10-14
ATE138976T1 (de) 1996-06-15
EP0537154A1 (en) 1993-04-21
CA2078861C (en) 1999-06-08
DE69120073T2 (de) 1996-11-07
GR3020965T3 (en) 1996-12-31
JP2550454B2 (ja) 1996-11-06
EP0537154B1 (en) 1996-06-05
US5366863A (en) 1994-11-22
WO1991015594A1 (en) 1991-10-17
JPH05509393A (ja) 1993-12-22
AU7556191A (en) 1991-10-30

Similar Documents

Publication Publication Date Title
DE69521608D1 (de) Verwendung von humanem neutrophil-lipocalin(hnl) als diagnostischer marker und anti-hnl-antikörperzubereitung
DK205287A (da) Bioklaebemidler til celle- og vaevsklaebning
NL980030I2 (nl) Combinatie van angiotensineomzetting-enzym-remmersmet calciumantagonisten alsmede de toepassing daarvan in medicijnen.
DE69233399D1 (de) Menschliches cyclin e
BR8500003A (pt) Processador de colheita e dispositivo de coleta de colheita
IT8619338A0 (it) Peptide sintetico ad attivita'interleukina 1 umana.
MY108526A (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
FI840640A0 (fi) Sensitiva tester baserade pao konstaterandet av dna foer paovisande av malignitet
DE68917684D1 (de) Untersuchungsventil und Messapparat für Bohrlöcher.
IT8567372A1 (it) Assorbente igienico e procedimento per la sua fabbricazione.
ES2089207T3 (es) Ensayo del contenido total de cadena alfa peptidica gonadotropica.
DE69024775D1 (de) Ventil- und Membranvorrichtung
ATE71149T1 (de) Monoklonale antikoerper.
ES2061566T3 (es) Anticuerpos monoclonales contra la proteina e7 del papilomavirus humano tipo 16, procedimiento para su preparacion, asi como su empleo.
IT8921789A0 (it) Reattivo per la ricerca e la determinazione della bilirubina nelle urine.
NO883743D0 (no) Framgangsmaate og anordning for aa gi personlig luftbehandling ("air-condition").
ES2056872T3 (es) Proteina pp4-x anticoagulante, su preparacion y empleo.
IT1150359B (it) Procedimento e dispositivo per effettuare misurazioni in serie,in particolare di dimensionie,oppure,proporzioni del corpo umano
IT7967403A0 (it) Procedimento e dispositivo per la determinazione del fabbisogno di ossigeno biologico
ES8707796A1 (es) Metodo para la cuantificacion del antigeno procoagulante delcancer en una muestra biologica
NO885511D0 (no) Fremgangsmaate og innretning for enkeltbestemmelsesblodanalyse.
NO157437C (no) Proeveinnretning for bestemmelse av blod i faeces.
NO912133L (no) Fremgangsmaate og proevekit for aa isolere trophoblastcellerfra blod.
NO885365D0 (no) Fluoriserende konjugater og biologisk diagnostisk analyse.
ITRM910344A0 (it) Procedimento di dosaggio della tireoglobulina e corredo (kit) per la sua utilizzazione.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 537154

Country of ref document: ES

FG2A Definitive protection

Ref document number: 537154

Country of ref document: ES